Bridges, et al.. The Risks and Benefits of Long-term Use of Hydroxyurea in Sickle Cell Anemia: A 17.5 Year Follow-up. The University of North Carolina at Chapel Hill University Libraries, 2010, doi:10.17615/y997-wd39.